Residual Symptoms After Carpal Tunnel Decompression and Treatment With Gabapentin: A Multicenter Study

dc.authoridCINAROGLU, Selim/0000-0002-4495-6106
dc.contributor.authorAydin, Murat
dc.contributor.authorArgun, Guldeniz
dc.contributor.authorAcar, Baver
dc.contributor.authorArikan, Murat
dc.contributor.authorCinaroglu, Selim
dc.contributor.authorMert, Ahmet
dc.contributor.authorTogral, Giiray
dc.date.accessioned2024-11-07T13:34:56Z
dc.date.available2024-11-07T13:34:56Z
dc.date.issued2021
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjectives To identify postoperative residual symptoms of carpal tunnel syndrome (CTS) and to investigate the effectiveness of gabapentin in the treatment of residual symptoms. Materials and methods Of a total of 412 patients who underwent surgery for CTS in four centers over a four-year period, 14 who had residual symptoms after CTS release and did not receive gabapentin (Group A) and 14 patients with postoperative residual symptoms and received gabapentin were included in this retrospective study. Postoperative residual symptoms were defined as persistent nocturnal numbness and tingling with or without occasional daytime pain. Tinel's and Phalen's tests were performed for the diagnosis of residual symptoms. Functional Severity Score (FSS), Symptom Severity Score (SSS), and Visual Analog Scale (VAS) were used to evaluate functional outcomes, severity of symptoms, and numbness and sleep quality, respectively at six and 12 weeks postoperatively. Results There was no statistically significant difference in the mean postoperative FSS (p=0.845) and VAS-numbness scores (p=0.367) between the groups. However, there was a statistically significant difference in the mean postoperative SSS (p=0.025) and VAS-sleep quality scores (p<0.001) between the groups. Conclusion Gabapentin treatment can be a treatment of choice for residual symptoms after CTS surgery and clinical improvement can be achieved owing to its relieving effect, particularly in nocturnal symptoms of patients having neuropathic pain.
dc.identifier.doi10.7759/cureus.17638
dc.identifier.issn2168-8184
dc.identifier.issue9
dc.identifier.pmid34646686
dc.identifier.urihttps://doi.org/10.7759/cureus.17638
dc.identifier.urihttps://hdl.handle.net/11480/16255
dc.identifier.volume13
dc.identifier.wosWOS:000692109800002
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringernature
dc.relation.ispartofCureus Journal of Medical Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectgabapentin
dc.subjectcarpal tunnel syndrome
dc.subjectneuralgia
dc.subjectdecompression
dc.subjectsurgical
dc.subjectpharmaceutical preparations
dc.titleResidual Symptoms After Carpal Tunnel Decompression and Treatment With Gabapentin: A Multicenter Study
dc.typeArticle

Dosyalar